Ironwood Pharmaceuticals
IRWD
#7014
Rank
NZ$1.20 B
Marketcap
NZ$7.31
Share price
6.17%
Change (1 day)
417.00%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2026 (TTM): NZ$0.29 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.36 Billion. In 2025 the company made an earning of NZ$0.11 Billion, an increase over its 2024 earnings that were of NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.29 B146.49%
2025 NZ$0.11 B7.4%
2024 NZ$0.11 B-106.88%
2023 -NZ$1.62 Billion-475.59%
2022 NZ$0.42 B25.8%
2021 NZ$0.34 B84.32%
2020 NZ$0.18 B84.69%
2019 NZ$0.10 B-125.13%
2018 -NZ$0.4 Billion100.62%
2017 -NZ$0.2 Billion43.12%
2016 -NZ$0.14 Billion-42.73%
2015 -NZ$0.25 Billion-24.76%
2014 -NZ$0.33 Billion-30.49%
2013 -NZ$0.47 Billion275.65%
2012 -NZ$0.13 Billion11.56%
2011 -NZ$0.12 Billion9.38%
2010 -NZ$0.11 Billion-15.21%
2009 -NZ$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
NZ$24.93 B 8,451.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-NZ$0.26 Billion-188.77%๐Ÿ‡บ๐Ÿ‡ธ USA